Open offer relaxation, preferential share allotment pricing norm changes likely among major changes to be made by Sebi Another proposal likely to be considered is the deposition of 100 percent money into an escrow account for an indirect acquisition. Currently, this is applicable for direct acquisition only.
Fortis and Religare 'vehemently' oppose sale of trademarks in Delhi High Court The court has been hearing a petition filed by Japanese drug firm Daiichi Sankyo seeking to attach and sell trademarks of Fortis and Religare and recover the amount due to it as per the Singapore tribunal arbitral award passed in April 2016.
Hospitals gear up to keep the virtual OPDs running even after Covid-19 Apollo Hospitals, Fortis Healthcare and Manipal Hospitals are among those that have accelerated the use of technology following the Covid-19 outbreak, with the lockdown restricting movement of people and hospital visits curtailed due to infection risk.
Buy Fortis Healthcare; target of Rs 160: ICICI Securities ICICI Securities is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 160 in its research report dated August 15, 2020.
Despite setting aside 1 in 3 beds for COVID cases, Fortis Healthcare says occupancy, realisations are subdued Most Fortis hospitals are concentrated in Delhi NCR and Mumbai, where Covid cases are on the decline and price caps are in place. With elective surgeries getting postponed, restrictions on international travel, and limited lockdowns in select States, non-Covid realisations have also taken a hit
What a 38-year-old turmeric scandal says about business in India The Supreme Court ended the 38-year saga of an alleged turmeric forger, who was arrested in 1982 and, eventually, sentenced to a month in jail and a 500 rupee ($6.70) fine. After a decade, the top court reversed his conviction; the two lower courts took around 14 years each to render verdicts.